TY - JOUR
T1 - Platelets and Neurodegenerative Diseases: Current Knowledge and Future Perspectives
AU - Gallo, Antonella
AU - Lipari, Alice
AU - Di Francesco, Silvino
AU - Ianuà, Eleonora
AU - Liperoti, Rosa
AU - Cipriani, Maria Camilla
AU - Martone, Anna Maria
AU - De Candia, Erica
AU - Landi, Francesco
AU - Montalto, Massimo
PY - 2024
Y1 - 2024
N2 - : Platelets have a fundamental role in mediating hemostasis and thrombosis. However, more recently, a new idea is making headway, highlighting the importance of platelets as significant actors in modulating immune and inflammatory responses. In particular, platelets have an important role in the development of vascular amyloid-b-peptide(ab) deposits, known to play a relevant role in Alzheimer's disease (AD) through accumulation and deposition within the frontal cortex and hippocampus in the brain. The involvement of platelets in the pathogenesis of AD opens up the highly attractive possibility of applying antiplatelet therapy for the treatment and/or prevention of AD, but conclusive results are scarce. Even less is known about the potential role of platelets in mild cognitive impairment (MCI). The aim to this brief review is to summarize current knowledge on this topic and to introduce the new perspectives on the possible role of platelet activation as therapeutic target both in AD and MCI.
AB - : Platelets have a fundamental role in mediating hemostasis and thrombosis. However, more recently, a new idea is making headway, highlighting the importance of platelets as significant actors in modulating immune and inflammatory responses. In particular, platelets have an important role in the development of vascular amyloid-b-peptide(ab) deposits, known to play a relevant role in Alzheimer's disease (AD) through accumulation and deposition within the frontal cortex and hippocampus in the brain. The involvement of platelets in the pathogenesis of AD opens up the highly attractive possibility of applying antiplatelet therapy for the treatment and/or prevention of AD, but conclusive results are scarce. Even less is known about the potential role of platelets in mild cognitive impairment (MCI). The aim to this brief review is to summarize current knowledge on this topic and to introduce the new perspectives on the possible role of platelet activation as therapeutic target both in AD and MCI.
KW - Alzheimer’s
KW - amyloid
KW - cognitive impairment
KW - platelets
KW - Alzheimer’s
KW - amyloid
KW - cognitive impairment
KW - platelets
UR - https://publicatt.unicatt.it/handle/10807/281979
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85197159075&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85197159075&origin=inward
U2 - 10.3390/ijms25126292
DO - 10.3390/ijms25126292
M3 - Article
SN - 1422-0067
VL - 25
SP - 6292-N/A
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
IS - 12
ER -